News Archive


Bartel research team wins prestigious AAAS Newcomb Cleveland Prize

February 16, 2003

The discovery of micro-sized RNA molecules (miRNAs)—a breakthrough described as "the biological equivalent of dark matter, all around us but almost escaping detection"—earned the coveted 2001-2002 AAAS Newcomb Cleveland Prize.

Statistics Show Strengths and Weaknesses of Genetics-Common Disease Studies

February 12, 2003

When the $100M HapMap project was announced late last year, it stoked a decades-long debate surrounding the “common-disease, common variant” hypothesis. Can hunting for links between common genetic variants and common diseases help reveal why some individuals are more susceptible to common diseases like diabetes and hypertension than others?

Harnessing the power of SiRNA

February 11, 2003

Whitehead Institute recently released for public use a new computational tool that can help researchers more precisely silence gene function, streamlining drug discovery and disease research efforts.

Beyond the Double Helix: Spring Lecture Series at the Museum of Science

January 23, 2003

Save the dates for this year's spring lecture series at the Boston Museum of Science, March 5, 12, and 19. This year's series, "Beyond the Double Helix," will feature Whitehead researchers who are taking a variety of new approaches to elucidate how genes and proteins coordinate cell activity and, in some cases, cause disease.

Lydia Villa-Komaroff, Maxine Singer Join Whitehead Leadership

January 21, 2003

On January 1, the Whitehead Institute welcomed Lydia Villa-Komaroff and Maxine Singer to its leadership ranks. Villa-Komaroff was named Vice President of Research and Chief Operating Officer for the Whitehead Institute; Singer assumed the Chairmanship of the Institute's Board of Directors.

Biotech 2010: Vision for the Future

January 13, 2003

Massachusetts can seize the opportunity to achieve global leadership in the life-sciences economy if the Commonwealth takes a more active state role in the promotion and support of biotechnology, according to a new report issued this month by the Massachusetts Biotechnology Council (MBC) and the Boston Consulting Group.

From Seashells to Nanocomputers

December 12, 2002

What can a humble seashell tell us about how to build biocomputers at the nanoscale level—50,000 times smaller than the width of a human hair? Plenty, according to Angela M. Belcher, Professor of Materials Science and Engineering and Bioengineering at the Massachusetts Institute of Technology.

The Mouse Genome and the Measure of Man

December 4, 2002

The Whitehead Institute Center for Genome Research and the International Mouse Genome Sequencing Consortium today announced the publication of the genetic blueprint of a mouse together with insights gleaned from comparing mouse and human sequences.

Vaccine Technology Homes in on Cancer

November 21, 2002

Whitehead Institute Member Richard Young's lab has discovered a unique approach to vaccine development, which is now in phase II and III human clinical trials for the cancer-causing human papilloma virus.

Whitehead Launches Affiliate Program

November 13, 2002

In today’s research arena, success requires biologists, physicians, chemists, mathematicians, and bioinformatics specialists to funnel unique expertise into shared projects. At Whitehead, interdisciplinary collaboration has fostered discoveries at the intersection of what were once disparate disciplines and has inspired the Institute to aggressively recruit diverse talent to the lab.

Ursinus to Bestow Honorary Degree on Director Susan Lindquist

November 5, 2002

Known for groundbreaking work in the study of the stress response and protein folding, Susan L. Lindquist, the Director of the Whitehead Institute for Biomedical Research, will receive an honorary degree from Ursinus College on Nov. 12, 2002.

Whitehead Genome Center Accelerates Effort to Build Haplotype Map

October 29, 2002

The Whitehead Institute Center for Genome Research is part of an international research consortium that today launched a $100 million public-private effort to build the next generation map of the human genome. Called a "haplotype map," this effort is expected to make it easier, faster, and perhaps cheaper to find genes that predispose us to common diseases such as diabetes and cancer.


© Whitehead Institute for Biomedical Research              455 Main Street          Cambridge, MA 02142